Russian scientists are reportedly working on a groundbreaking gene therapy drug, spearheaded by President Vladimir Putin, with the goal of delaying the aging process. This ambitious project centers on blocking the RAGE gene, believed to be a key factor in cellular aging.

Putin's Obsession with Longevity

The initiative is driven by Putin’s well-documented interest in extending his lifespan and speculation about a potential dynastic succession, possibly involving his son, Ivan Spirodonov. Researchers are striving to develop the “world’s first” drug to block the RAGE gene, potentially slowing or reversing aging, according to Russian science and education minister Denis Sekirinsky.

Kremlin Control and Research Demands

Recent reports indicate that Russian scientists were urgently directed to submit all anti-aging research to the Kremlin. This directive suggests a focused effort to benefit Putin and his close associates, many of whom are in their seventies.

Scope of the Research

The Kremlin’s request encompassed a broad range of areas, including technologies to prevent cell deterioration, address cognitive and sensory impairment, correct immune deficiencies, and advance bioprinting for organ regeneration. These demands highlight the importance placed on achieving breakthroughs in longevity.

International Discussions and Past Efforts

Captured conversations reveal Putin discussing the possibility of achieving immortality with Chinese President Xi Jinping and North Korean leader Kim Jong Un. This suggests a wider interest in radical life extension strategies, including organ transplants and advanced medical procedures.

The passing of Professor Vladimir Khavinson, Putin’s former anti-aging advisor, last year underscored the challenges of current life extension methods. Khavinson had previously claimed to be close to unlocking a lifespan of 110 to 120 years and reportedly provided experimental cocktails to Putin and Alina Kabaeva.

National Project and Contrasting Realities

Despite this setback, the Kremlin has intensified its commitment to longevity research, launching a national project aiming to preserve the health of its citizens and save 175,000 lives by 2030. However, this focus on extending life within Russia contrasts sharply with the ongoing loss of life in the conflict in Ukraine.

Some analysts suggest Putin’s goal may not be a lifespan of 150 years, but rather reaching the age of 97, allowing his son Ivan to become eligible for the presidency in 2050. Putin’s daughter, Maria Vorontsova, an endocrinologist, is also reportedly involved in the research.